argenx to Present at TD Cowen 46th Annual Healthcare Conference
argenx (Euronext & Nasdaq: ARGX) announced that Karen Massey, Chief Operating Officer, will speak in a fireside chat at the TD Cowen 46th Annual Healthcare Conference on Monday, March 2, 2026 at 11:50 a.m. ET.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
argenx (Euronext & Nasdaq: ARGX) announced that Karen Massey, Chief Operating Officer, will speak in a fireside chat at the TD Cowen 46th Annual Healthcare Conference on Monday, March 2, 2026 at 11:50 a.m. ET.
According to the company, a live webcast will be available on the Investors section of the argenx website, with a replay accessible for approximately 30 days after the presentation.
Details
News Market Reaction – ARGX
On Feb 23, the day this news came out, ARGX closed 2.15% below the previous close.
Data tracked by StockTitan Argus for the Feb 23 session.
Key Figures
- Conference edition
- 46th Annual
- TD Cowen Healthcare Conference
- Conference date
- March 2
- TD Cowen fireside chat date
- Presentation time
- 11:50 a.m. ET
- Scheduled time for fireside chat
- Webcast replay period
- 30 days
- Replay availability on argenx website
Historical Context
-
Scheduled full-year 2025 results and Q4 update call announcement.
-
FDA acceptance of VYVGART sBLA with Priority Review and set PDUFA date.
-
Strong 2025 sales, 2026 strategic priorities, and pipeline expansion plans.
-
Announcement of presentation at J.P. Morgan Healthcare Conference.
-
CEO transition and board changes subject to shareholder approval.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
February 23, 2026
Amsterdam, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced that Karen Massey, Chief Operating Officer, will participate in a fireside chat at the TD Cowen 46th Annual Healthcare Conference on Monday, March 2 at 11:50 a.m. ET.
A live webcast of the presentation may be accessed on the Investors section of the argenx website at argenx.com/investors. A replay of the webcast will be available on the argenx website for approximately 30 days following the presentation.
About argenx
argenx is a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases. Partnering with leading academic researchers through its Immunology Innovation Program (IIP), argenx aims to translate immunology breakthroughs into a world-class portfolio of novel antibody-based medicines. argenx developed and is commercializing the first approved neonatal Fc receptor (FcRn) blocker and is evaluating its broad potential in multiple serious autoimmune diseases while advancing several earlier stage experimental medicines within its therapeutic franchises. For more information, visit www.argenx.com and follow us on LinkedIn, Instagram, Facebook, and YouTube.
Contacts
Media:
Ben Petok
bpetok@argenx.com
Investors:
Alexandra Roy
aroy@argenx.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.